PNC Financial Services Group’s Takeda Pharmaceutical TAK Stock Holding History

PNC Financial Services Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$798K	Sell	49,797 -6,917	-12%	-$114K	﹤0.01%	1508
2026 Q1	$1.05M	Sell	56,714 -2,168	-4%	-$38K	﹤0.01%	1279
2025 Q4	$918K	Sell	58,882 -14,668	-20%	-$210K	﹤0.01%	1306
2025 Q3	$1.08M	Buy	73,550 +4,436	+6%	+$65.9K	﹤0.01%	1217
2025 Q2	$1.07M	Buy	69,114 +10,544	+18%	+$156K	﹤0.01%	1152
2025 Q1	$871K	Sell	58,570 -139	-0.2%	-$1.95K	﹤0.01%	1222
2024 Q4	$777K	Buy	58,709 +3,392	+6%	+$46.6K	﹤0.01%	1278
2024 Q3	$787K	Buy	55,317 +176	+0.3%	+$2.5K	﹤0.01%	1275
2024 Q2	$714K	Sell	55,141 -13,419	-20%	-$178K	﹤0.01%	1292
2024 Q1	$952K	Sell	68,560 -3,172	-4%	-$46.1K	﹤0.01%	1177
2023 Q4	$1.02M	Sell	71,732 -255,384	-78%	-$3.62M	﹤0.01%	1115
2023 Q3	$5.06M	Sell	327,116 -4,148	-1%	-$64.2K	﹤0.01%	625
2023 Q2	$5.2M	Sell	331,264 -17,372	-5%	-$285K	﹤0.01%	627
2023 Q1	$5.75M	Sell	348,636 -7,085	-2%	-$113K	0.01%	604
2022 Q4	$5.55M	Sell	355,721 -10,786	-3%	-$151K	0.01%	609
2022 Q3	$4.75M	Buy	366,507 +27,286	+8%	+$379K	0.01%	624
2022 Q2	$4.76M	Sell	339,221 -32,175	-9%	-$459K	﹤0.01%	646
2022 Q1	$5.32M	Sell	371,396 -30,315	-8%	-$445K	﹤0.01%	663
2021 Q4	$5.47M	Sell	401,711 -48,403	-11%	-$679K	﹤0.01%	674
2021 Q3	$7.37M	Buy	450,114 +1,968	+0.4%	+$33K	0.01%	563
2021 Q2	$7.54M	Buy	448,146 +10,887	+2%	+$185K	0.01%	561
2021 Q1	$7.99M	Sell	437,259 -5,452	-1%	-$98.1K	0.01%	538
2020 Q4	$8.06M	Sell	442,711 -439	-0.1%	-$7.7K	0.01%	516
2020 Q3	$7.91M	Sell	443,150 -29,158	-6%	-$531K	0.01%	502
2020 Q2	$8.47M	Sell	472,308 -80,868	-15%	-$1.45M	0.01%	475
2020 Q1	$8.4M	Sell	553,176 -21,084	-4%	-$382K	0.01%	441
2019 Q4	$11.3M	Buy	574,260 +1,949	+0.3%	+$37.3K	0.01%	441
2019 Q3	$9.84M	Sell	572,311 -33,725	-6%	-$583K	0.01%	496
2019 Q2	$10.7M	Sell	606,036 -5,319	-0.9%	-$96.8K	0.01%	502
2019 Q1	$12.5M	Buy	611,355 +320,650	+110%	+$6.45M	0.01%	466
2018 Q4	$4.89M	Buy	+290,705	New	+$4.91M	0.01%	685

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

PNC Financial Services Group's TAK Position: Q2 2026 in Review

PNC Financial Services Group reduced its Takeda Pharmaceutical (TAK) stake by 12% in Q2 2026, selling an estimated $114K and leaving 49,797 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

PNC Financial Services Group first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $12.5M in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

PNC Financial Services Group held 49,797 shares of Takeda Pharmaceutical worth $798K as of Q2 2026.
PNC Financial Services Group sold 6,917 Takeda Pharmaceutical shares in Q2 2026, an estimated $114K.
Takeda Pharmaceutical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1508 holding.
PNC Financial Services Group first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
PNC Financial Services Group's Takeda Pharmaceutical position peaked at $12.5M in Q1 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.